Elevation Oncology Inc (NASDAQ:ELEV)

1.27
Delayed Data
As of 3:59pm ET
 +0.02 / +1.60%
Today’s Change
1.12
Today|||52-Week Range
13.39
-78.90%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Elevation Oncology Inc have a median target of 9.50, with a high estimate of 11.00 and a low estimate of 8.00. The median estimate represents a +648.03% increase from the last price of 1.27.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Elevation Oncology Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.47
Sales
$0.00
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -70.52%
 
 
 
 
 
 
Growthannually -48.96%
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.